Richard Kim
2020
Compensation breakdown
| Non-Equity Incentive Plan | $168,056 |
|---|---|
| Option Awards | $505,128 |
| Salary | $456,095 |
| Stock Awards | $1,044,360 |
| Other | $79,211 |
| Total | $2,252,850 |
Kim received $1M in stock awards, accounting for 46% of the total pay in 2020.
Kim also received $168.1K in non-equity incentive plan, $505.1K in option awards, $456.1K in salary and $79.2K in other compensation.
Rankings
In 2020, Richard Kim's compensation ranked 4,994th out of 13,090 executives tracked by ExecPay. In other words, Kim earned more than 61.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,994 out of 13,090 | 62nd |
Division Manufacturing | 2,036 out of 5,621 | 64th |
Major group Chemicals And Allied Products | 811 out of 2,254 | 64th |
Industry group Drugs | 700 out of 1,954 | 64th |
Industry Pharmaceutical Preparations | 526 out of 1,459 | 64th |
Pay ratio
| Richard Kim's Pay | $2,252,850 |
|---|---|
| Median Employee's Pay | $267,493 |
| Pay Ratio | 8to 1 |
In 2020, the annual total compensation of Richard Kim was $2,252,850.
The annual total compensation of the median employee at Intercept Pharmaceuticals was $267,493.
The ratio of Richard Kim's pay to the pay of median employee was therefore 8 to one.
Kim's colleagues
We found six more compensation records of executives who worked with Richard Kim at Intercept Pharmaceuticals in 2020.
2020
Mark Pruzanski
Intercept Pharmaceuticals
Chief Executive Officer
2020
Jerome Durso
Intercept Pharmaceuticals
Chief Operating Officer
2020
Sandip Kapadia
Intercept Pharmaceuticals
Chief Financial Officer
2020
Lisa Bright
Intercept Pharmaceuticals
Former President, International
2020
Ryan Sullivan
Intercept Pharmaceuticals
General Counsel
2020
Christian MAS
Intercept Pharmaceuticals